genomic diagnostics

Innovative diagnostic tools are reshaping clinical decision-making in 2026 as biotechnology companies, health systems, and regulators push for faster, more precise disease detection. Advances in molecular diagnostics, artificial intelligence enabled imaging, and decentralized testing platforms are expanding how clinicians identify disease earlier and monitor patients more effectively. In the United States, diagnostic innovation increasingly intersects … Read more